nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A modeling and simulation-based assessment of the impact of confounding factors on the readout of a sildenafil survival trial in pulmonary arterial hypertension
|
Chanu, Pascal |
|
2019 |
46 |
5 |
p. 499-509 |
artikel |
2 |
A physiologically-motivated model of cystic fibrosis liquid and solute transport dynamics across primary human nasal epithelia
|
Serrano Castillo, Florencio |
|
2019 |
46 |
5 |
p. 457-472 |
artikel |
3 |
A quantitative systems pharmacology model of colonic motility with applications in drug development
|
Das, Raibatak |
|
2019 |
46 |
5 |
p. 485-498 |
artikel |
4 |
Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
|
Chelle, Pierre |
|
2019 |
46 |
5 |
p. 439 |
artikel |
5 |
Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization
|
McEneny-King, Alanna |
|
2019 |
46 |
5 |
p. 411-426 |
artikel |
6 |
Editorial to the themed issue on application of pharmacometrics to the development of drugs for rare diseases
|
Bonate, Peter |
|
2019 |
46 |
5 |
p. 385-386 |
artikel |
7 |
FDA’s Office of Orphan Products Development: providing incentives to promote the development of products for rare diseases
|
Patel, Soumya |
|
2019 |
46 |
5 |
p. 387-393 |
artikel |
8 |
Modeling and simulation of the modified Rankin Scale and National Institutes of Health Stroke Scale neurological endpoints in intracerebral hemorrhage
|
Schoemaker, Rik |
|
2019 |
46 |
5 |
p. 473-484 |
artikel |
9 |
Orphan drug development: the increasing role of clinical pharmacology
|
Ahmed, Mariam A. |
|
2019 |
46 |
5 |
p. 395-409 |
artikel |
10 |
Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
|
Chelle, Pierre |
|
2019 |
46 |
5 |
p. 427-438 |
artikel |
11 |
Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy
|
Conrado, Daniela J. |
|
2019 |
46 |
5 |
p. 441-455 |
artikel |